The Group's principal activities are the production and distribution of technologies for the separation, purification and handling of DNA, RNA and proteins. The Group also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. The Group's products are used in biological research, research institutions, forensics, diagnostic and therapeutic industries. Brand names include QIAexpress, QIAwell, QIAEX and QIAprep. The Group operates worldwide. It acquired Corbett Life Science Pty. Ltd. in 2008.
Alacra Alerts:
Receive alerts on the latest reports on Qiagen N.V.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
